Search archive

Advanced search

Jardine Lloyd Thompson Limited (JLT) has launched a White Paper to warn life science companies of "many of the typical deficiencies that occur with disturbing regularity" in product liability cover.

The highly-regulated biotechnology, pharmaceuticals, chemicals and medical devices sectors have been witnessing increasing legal action as a result of a more litigious operating environment and product recalls as global supply chains grow in complexity. The sector also faces emerging risks such as healthcare reform and intellectual property theft.

"We have...

---

You are currently viewing an incomplete version of this article. If you are a subscriber then please login now. If you are a non-subscriber but would like to be able to view this article, then please select from the purchasing options below.

---

Email Address

Password

• Subscription
  Inside FAC